DaVita (MIL:1DVA) Tariff Resilience Score: 8/10 (As of Jul. 12, 2026)


MIL:1DVA DaVita Inc MIL:1DVA
61 GF Score
Price €207.10
GF Value €148.57
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is DaVita Tariff Resilience Score?

DaVita MIL:1DVA 61 Tariff Resilience Score is 8 as of Jul. 12, 2026. GuruFocus rates MIL:1DVA with a GF Score™ of 61/100 and a GF Value™ of €148.57 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 672 Healthcare Providers & Services companies, DaVita ranks better than 96.58% on this metric.

DaVita has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

DaVita has DaVita Inc has low tariff vulnerability due to its focus on healthcare services, which are less affected by trade tariffs. The company operates mainly in the U.S., with limited international supply chain dependencies. Historical tariff impacts have been minimal.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes DaVita might have Highly Resilient.


DaVita  (MIL:1DVA) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

DaVita Tariff Resilience Score Related Terms


MIL:1DVA vs THC, EHC, ENSG: Tariff Resilience Score Comparison

For the Medical Care Facilities subindustry, DaVita's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where DaVita's Tariff Resilience Score falls into.


MIL:1DVA
61GF Score
DaVita Inc MIL:1DVA
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
DaVita (MIL:1DVA) has a Tariff Resilience Score of 8 as of Jul. 12, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, DaVita ranks #23 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 3.4%.
Is DaVita's Tariff Resilience Score too high?
DaVita's current Tariff Resilience Score is 8. Based on the distribution chart, DaVita ranks #23 out of 672 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DaVita has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DaVita's Tariff Resilience Score compare to THC and EHC?
According to the Healthcare Providers & Services industry distribution chart, DaVita ranks #23 out of 672 companies for Tariff Resilience Score. This places DaVita in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. DaVita's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (MIL:1DVA) is currently considered Significantly Overvalued. The stock's GF Value™ is €148.57, compared to a current price of €207.10 — trading 39.4% above its estimated fair value. The current Tariff Resilience Score is 8. DaVita's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For DaVita (MIL:1DVA), the current Tariff Resilience Score is 8 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DaVita (MIL:1DVA) Overvalued in 2026?

Based on GuruFocus' analysis, DaVita stock appears to be overvalued. The current stock price of €207.10 is trading 39.4% above its estimated GF Value™ of €148.57. GuruFocus considers DaVita to be Significantly Overvalued.

Key valuation signals for MIL:1DVA:

  • Tariff Resilience Score: 8
  • GF Value™: €148.57 vs. price of €207.10 (39.4% above fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the MIL:1DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DaVita Business Description

Address 2000 16th Street, Denver, CO, USA, 80202
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
61GF Score

Get the complete analysis for MIL:1DVA

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€207.10
Price
€148.57
GF Value